What happens when artificial intelligence systems start to think for themselves, make themselves more powerful and escape human control in their quest to achieve superintelligence? That prospect has ...

Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

Photo: Jesse Faatz via Billy Strings Facebook — David Grisman with Billy Strings and his band in Washington, 10/10/26 Saturday’s sit-in included multiple live debuts for Billy’s band, including ...

Billy Strings' late mother, Debra Apostol, introduced the three-time Grammy award-winning musician to alternative music early in his life. "I remember her playing [The Beatles'] White Album backwards ...

The first-ever Ionia Freak Fair took place on Friday and Saturday at the Ionia Fairgrounds in Ionia, MI. The epic weekend curated by Billy Strings who grew up in the area. In addition to Strings and ...

The acclaimed bluegrass artist's latest album is a profound meditation on grief inspired by the recent death of his mother. By Eric Renner Brown Over the last few years, virtuosic bluegrass player ...

Billy Strings returned to Theo Von’s This Past Weekend podcast for a nearly three-hour conversation that touched on fatherhood, addiction, grief, his upcoming album and a recent injury. But perhaps ...

Lady Be Good; Gone With The Wind; Autumn Leaves; Kelly's Blues; Destination Moon; Deed I Do; The Very Thought of You; Exactly Like You. On his new live album, jazz piano virtuoso Mike Jones embraces ...

After nearly five years of collaboration, Roche and Recursion Pharmaceuticals have something concrete to show for it. On August 5, 2026, the two companies confirmed that their first AI-identified drug ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...